EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative Review

Marianne Martinello iD, Susanna Naggie, Juergen Kurt Rockstroh, Gail V Matthews

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciad344 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Marianne Martinello und 3 weiteren Autor:innen. Beteiligte Einrichtung: Kirby Institute, University of New South Wales (UNSW Sydney), Sydney, Australia. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Hepatitis C. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Following the discovery of hepatitis C virus (HCV) in 1989, 3 decades of basic, translational, and clinical research culminated in the development of direct-acting antiviral (DAA) therapy—curative oral treatment for HCV infection. The availability of DAA therapy revolutionized HCV clinical management, including acute (duration of infection <6 mo) and recent (duration of infection <12 mo) infection. Several DAA regimens, including the contemporary pan-genotypic combinations of sofosbuvir-velpatasvir and glecaprevir-pibrentasvir, have been shown to be safe and effective among people with acute and recent HCV infection, highlighting their potential in an HCV controlled human infection model. This article describes the natural history and management of acute and recent HCV infection in the era of DAA therapy and outlines a strategy for use of DAA therapies in the setting of an HCV controlled human infection model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis C, ChronicHepatitis CHumansAntiviral AgentsHepacivirusSofosbuvirDrug Therapy, CombinationGenotype

Stichwörter der Autor:innen

DAAHCVHIVmen-who-have-sex-with-menpeople who inject drugs

Substanzen

Antiviral AgentsSofosbuvir

Autor:innen und Institutionen

  • Kirby Institute, University of New South Wales (UNSW Sydney), Sydney, Australia.
  • Prince of Wales Hospital, Sydney, Australia.
  • Duke University Medical Center, Durham, North Carolina, USA.
  • Duke Clinical Research Institute, Durham, North Carolina, USA.
  • University Hospital Bonn, Bonn, Germany.
  • St Vincent's Hospital, Sydney, Australia.

ORCID-Profile: Marianne Martinello

Zitieren

APA

Martinello, M., Naggie, S., Rockstroh, J. K., & Matthews, G. V. (2023). Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative Review. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad344

Vancouver

Martinello M, Naggie S, Rockstroh JK, Matthews GV. Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative Review. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad344

BibTeX
@article{Martinello2023,
  author = {Martinello, Marianne and Naggie, Susanna and Rockstroh, Juergen Kurt and Matthews, Gail V},
  title = {Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative Review},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciad344}
}
Kostenlos starten →